Evidence map›Paper›PMID 33496229›Full record

ArticleEmerging infectious diseases2021

Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010-2018.

Kiersten J Kugeler, Amy M Schwartz, Mark J Delorey, Paul S Mead, Alison F Hinckley

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 363 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
363citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

363 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Lyme Disease and Other Tick-Borne Infections.Current neurology and neuroscience reports · 2026
    Review
  7. Serological correlates of disseminatedMicrobiology spectrum · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Colonization of 3D-organotypic human skin by the Lyme Disease pathogen,bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Glycolytic reprogramming in host response toExperimental and therapeutic medicine · 2026
    Article
  19. Article
  20. Article

303 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kiersten J Kugeler
Amy M Schwartz
Mark J Delorey
Paul S Mead
Alison F Hinckley

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By using commercial insurance claims data, we estimated that Lyme disease was diagnosed and treated in ≈476,000 patients in the United States annually during 2010-2018. Our results underscore the need for accurate diagnosis and improved prevention.

Indexed as

Borrelia burgdorferiLyme DiseaseHumansUnited StatesbacteriaBorrelia burgdorferidiagnosesdisease burdeninsurance claimsLyme diseaseUnited Statesvector-borne infections

Identifiers

PMID33496229
PMCPMC7853543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.